Global banking giant Sumitomo Mitsui Banking Corp. (SMBC) is reportedly nearing a lease agreement for approximately 200,000 square feet in the former One Wells Fargo Center in uptown Charlotte. This move is expected to house a 2,000-job financial hub, fulfilling plans announced previously for a major financial services center in the city. SMBC's decision comes after selecting Charlotte over Jacksonville for its new hub.

Thermo Fisher Scientific (TMO) recently announced a collaboration with Precision Health Research, Singapore for the PRECISE-SG100K biobank, aiming to advance precision medicine. Despite a mixed stock performance with a recent gain but year-to-date decline, analysts value the stock at a higher target price than its current trading price. The article discusses two valuation narratives: one suggesting it's undervalued based on long-term demand, and another flagging caution due to its P/E ratio.

Vulcan Materials (VMC) is approaching its Q1 2026 earnings release, with investor focus on potential profit growth driven by infrastructure and data center demand. While recent share price momentum is positive, the stock is trading below the average analyst target and its intrinsic value, with one narrative suggesting it's 9.8% undervalued due to its market position in growing urban areas. However, its high P/E ratio compared to industry peers suggests it might be expensive, leading to mixed sentiment on its valuation.

The Shareholders Foundation announced a lawsuit deadline of May 26, 2026, for investors who incurred losses exceeding $100,000 from purchasing Super Micro Computer, Inc. (NASDAQ: SMCI) shares between April 30, 2024, and March 19, 2026. The lawsuit alleges that Super Micro Computer failed to disclose that a significant portion of its server sales to Chinese companies violated U.S. export control laws and that there were material weaknesses in the company's compliance controls. Investors affected by these alleged securities law violations are encouraged to contact the Shareholders Foundation.

This article examines whether Salesforce's significant push into AI, particularly with its Agentforce platform and Data Cloud, can fuel its next phase of growth and justify its premium valuation. It highlights Salesforce's dominant position in the CRM market, its recurring revenue model, and its strategic priorities including AI ubiquity, international expansion, and efficiency. The piece also discusses analyst views, risks like macroeconomic sensitivity and competition, and what investors should monitor next.

Jim Cramer continues to advocate for investing in the defense sector, highlighting L3Harris Technologies, Inc. (NYSE:LHX) as a key player. He emphasized L3Harris's growth through acquisitions, particularly Aerojet Rocketdyne, which he believes is crucial for rebuilding missile stockpiles. The company is noted for its diverse defense offerings, including communication systems, space technology, electronic warfare, and counter-drone products.

Conagra Brands (CAG) stock dropped 4.8% following the announcement of a leadership transition. John Brase will take over as President and CEO from Sean Connolly, effective June 1, 2026, creating investor uncertainty despite Brase's deep packaged-food experience. The article also details recent insider trading, hedge fund activity, government contracts, congressional stock trading, and analyst ratings for CAG.

Today is the final day for eligible customers to claim their share of an $8.5 million cash settlement from Dollar General, following accusations of charging customers higher prices at the register than advertised on shelves. Consumers who purchased merchandise at Dollar General stores nationwide between October 10, 2016, and November 19, 2025, may qualify for cash payouts or an in-store discount. Claims must be submitted via DGPriceSettlement.com by the end of today, April 13, 2026.

Progyny Inc. (US74340E1038) is positioned as a key player in the growing U.S. fertility benefits market, providing an employer-sponsored platform that covers a range of fertility and family-building services. The company's model emphasizes high-touch support, data analytics for optimized outcomes, and partnerships with top clinics, creating predictable cash flows tied to employment trends. With strong retention rates and a focus on specialized services, analysts maintain a positive outlook for Progyny despite potential risks from regulatory changes or intensified competition.

Mizuho analyst Yaron Kinar raised the price target for Everest Group Ltd (EG) to $365, up from $360, while maintaining a Neutral rating. Despite this, GuruFocus assesses EG as 19.5% undervalued with a GF Value™ of $413.06 and a strong GF Score™ of 78/100, highlighting good profitability and growth but low momentum. Insiders have shown no recent buying or selling activity.